JULI TAYLOR: Open Payments
NPI 1568544369 · NEW CASTLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 25 payments from 8 companies in 2025. Trend: 2023 $398 · 2024 $166 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $146 |
| Lundbeck LLC | 2 | $42 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Medtronic, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Abbott Laboratories | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 4 | $16 |
Products named: VRAYLAR, REXULTI, INGREZZA, UBRELVY, QULIPTA, CAPLYTA, INTELLIS ADAPTIVESTIM, Veozah.
Industry payments across IN — which companies pay providers there.
